News

Massive Bio, a leader in AI-powered oncology clinical trial matching, today announced the launch of its new key feature on the Patient Connect app. This integration will empower both patients and healthcare providers

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its enterprise imaging solution as a fully managed cloud service, Sectra One Cloud, to a leading medical center in the US.

Arctx Medical, Inc, a clinical-stage medical device company, announced today that it has achieved three significant milestones:

Varian, a Siemens Healthineers company, has announced the successful completion of enrollment and treatment in its FAST-02 (Flash Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax) clinical trial.

Leading correctional healthcare company, NaphCare, Inc., today announced the successful implementation of TechCare, NaphCare’s innovative electronic health record (EHR) system, across the Georgia Department of Corrections

Nusano, a physics company transforming the production of radioisotopes, today cut the ribbon on its 190,000-square-foot radioisotope production facility. The site will be capable of producing more than 40 different radioisotopes

Signos, a purpose-driven metabolic health platform committed to transforming lives through personalized, real-time insights, today announced the launch of Signos Glucose Monitoring System, the first ever FDA-cleared

RedDress, the developer and manufacturer of the FDA-cleared ActiGraft® wound management system, today announced an exclusive distribution agreement with Legacy Medical Consultants (LMC)

Butterfly Network, Inc, a digital health company transforming care with handheld, whole-body ultrasound, today announced its role in the international research study CAD LUS4TB that will evaluate the impact of AI-assisted

Nerveblox, an AI software solution by SmartAlpha, designed to assist physicians in using ultrasound while administering regional anesthesia procedures commonly known as 'nerve blocks', has received U.S. Food and Drug Administration